Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids - PubMed (original) (raw)

. 1992 Sep 24;359(6393):325-7.

doi: 10.1038/359325a0.

Affiliations

• PMID: 1406936
• DOI: 10.1038/359325a0

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

P Seubert et al. Nature. 1992.

Abstract

Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.

PubMed Disclaimer

Comment in

• Alzheimer's disease. In search of the soluble.
  Hardy J, Mullan M. Hardy J, et al. Nature. 1992 Sep 24;359(6393):268-9. doi: 10.1038/359268a0. Nature. 1992. PMID: 1406927 No abstract available.

Similar articles

• Humoral immune response to fibrillar beta-amyloid peptide.
  Miller DL, Currie JR, Mehta PD, Potempska A, Hwang YW, Wegiel J. Miller DL, et al. Biochemistry. 2003 Oct 14;42(40):11682-92. doi: 10.1021/bi030100s. Biochemistry. 2003. PMID: 14529278
• Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.
  Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ, et al. Seubert P, et al. Nature. 1993 Jan 21;361(6409):260-3. doi: 10.1038/361260a0. Nature. 1993. PMID: 7678698
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.
  Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, et al. Haass C, et al. Nature. 1992 Sep 24;359(6393):322-5. doi: 10.1038/359322a0. Nature. 1992. PMID: 1383826
• Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
  Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM. Liu K, et al. Acta Neuropathol. 2006 Aug;112(2):163-74. doi: 10.1007/s00401-006-0077-5. Epub 2006 Jun 1. Acta Neuropathol. 2006. PMID: 16865398
• [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
  Fukatsu R, Tsuzuki K, Hayashi Y, Takamaru Y, Sasaki N, Yoshida T, Hatakeyama Y, Fuji N, Takahata N. Fukatsu R, et al. Hokkaido Igaku Zasshi. 1997 Jan;72(1):3-11. Hokkaido Igaku Zasshi. 1997. PMID: 9086357 Review. Japanese.

Cited by

• Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction?
  Peric A, Annaert W. Peric A, et al. Acta Neuropathol. 2015 Mar;129(3):363-81. doi: 10.1007/s00401-014-1379-7. Epub 2015 Jan 3. Acta Neuropathol. 2015. PMID: 25556159 Free PMC article. Review.
• Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift.
  LaDu MJ, Munson GW, Jungbauer L, Getz GS, Reardon CA, Tai LM, Yu C. LaDu MJ, et al. Biochim Biophys Acta. 2012 Feb;1821(2):295-302. doi: 10.1016/j.bbalip.2011.11.005. Epub 2011 Nov 23. Biochim Biophys Acta. 2012. PMID: 22138302 Free PMC article.
• Aβ-40 Y10F increases βfibrils formation but attenuates the neurotoxicity of amyloid-β peptide.
  Dai X, Chang P, Liu W, Xu K, Sun Y, Zhu S, Jiang Z. Dai X, et al. Int J Mol Sci. 2012;13(5):5324-5337. doi: 10.3390/ijms13055324. Epub 2012 Apr 25. Int J Mol Sci. 2012. PMID: 22754299 Free PMC article.
• Comparison of the Amyloid Plaque Proteome in Down Syndrome, Early-Onset Alzheimer's Disease and Late-Onset Alzheimer's Disease.
  Martá-Ariza M, Leitner DF, Kanshin E, Suazo J, Pedrosa AG, Thierry M, Lee EB, Devinsky O, Drummond E, Fortea J, Lleó A, Ueberheide B, Wisniewski T. Martá-Ariza M, et al. Res Sq [Preprint]. 2024 Jul 15:rs.3.rs-4469045. doi: 10.21203/rs.3.rs-4469045/v1. Res Sq. 2024. PMID: 39070643 Free PMC article. Preprint.
• Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology.
  Moon M, Song H, Hong HJ, Nam DW, Cha MY, Oh MS, Yu J, Ryu H, Mook-Jung I. Moon M, et al. Cell Death Differ. 2013 Apr;20(4):630-8. doi: 10.1038/cdd.2012.161. Epub 2012 Dec 21. Cell Death Differ. 2013. PMID: 23257976 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource